Search

Search Results
Results 1361 - 1370 of 1408 for hodgkin's lymphoma
  • Tumor Lysis Syndrome
    Health - 14 Apr 2021
    Tumor lysis syndrome represents a potentially fatal complication of cancer treatment that is usually seen in patients with rapidly growing, extensive and chemosensitive malignant tumors. This clinical...
  • How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment
    Life Sciences - 11 Mar 2020
    Immune checkpoint inhibitors have emerged as a revolutionary type of cancer immunotherapy.
  • Targeting the Immune System for Cancer Treatment with Small Molecules
    White Paper - 18 Mar 2019
    Small molecules provide an advantage over biologicals, and can be used to target the immune system as a form of cancer treatment.
  • Paraneoplastic Pemphigus
    Health - 27 Feb 2019
    Pemphigus diseases are a rare group of autoimmune conditions characterized by the formation of blisters that affect the skin and / or mucous membranes. Paraneoplastic pemphigus (PNP) is a rare form of...
  • Chronic Lymphocytic Leukemia (CLL) Prognosis
    Health - 26 Feb 2019
    Chronic lymphocytic leukemia (CLL) may likely arouse queries in patients about factors like prognosis and survival, both of which are based on numerous aspects.
  • Cutaneous Manifestations of Internal Malignancy
    Health - 26 Feb 2019
    Internal malignancies such as cancers can develop external signs on the skin called cutaneous markers or manifestations. These signs may show prior to, during, or after a cancer has been detected.
  • Causes of Calcification
    Health - 26 Feb 2019
    The abnormal accumulation of calcium in tissues where it should not be physiologically found happens as a result of many factors. This build-up of mineral may occur in specific tissues / organs or...
  • What is B-Raf?
    Life Sciences - 26 Feb 2019
    B-Raf is a protein encoded by the BRAF gene and is involved in the RAS/MAPK pathway, which regulates cellular growth and division.
  • Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018
    News - 5 Nov 2018
    Amgen today announced that new clinical data will be presented at the 60th American Society of Hematology Annual Meeting & Exposition in San Diego, Dec. 1-4, 2018. Data across an array of malignancies...
  • Antibody-Drug Conjugates: History and Development
    Life Sciences - 30 Aug 2018
    A drug delivery method commonly used in oncology is antibody-drug conjugates, the first trial of which began in 1982.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback